Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Intercept_Pharmaceuticals> ?p ?o. }
Showing items 1 to 44 of
44
with 100 items per page.
- Intercept_Pharmaceuticals abstract "Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC), non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.".
- Intercept_Pharmaceuticals foundingYear "2002".
- Intercept_Pharmaceuticals industry Biotechnology.
- Intercept_Pharmaceuticals keyPerson Chief_executive_officer.
- Intercept_Pharmaceuticals keyPerson President.
- Intercept_Pharmaceuticals locationCity New_York.
- Intercept_Pharmaceuticals locationCity New_York_City.
- Intercept_Pharmaceuticals locationCountry United_States.
- Intercept_Pharmaceuticals wikiPageExternalLink about.
- Intercept_Pharmaceuticals wikiPageID "42261752".
- Intercept_Pharmaceuticals wikiPageRevisionID "604185629".
- Intercept_Pharmaceuticals foundation "2002".
- Intercept_Pharmaceuticals industry Biotechnology.
- Intercept_Pharmaceuticals keyPeople "Jonathan Silverstein".
- Intercept_Pharmaceuticals keyPeople "Mark Pruzanski".
- Intercept_Pharmaceuticals locationCity New_York.
- Intercept_Pharmaceuticals locationCity New_York_City.
- Intercept_Pharmaceuticals locationCountry United_States.
- Intercept_Pharmaceuticals logo "200".
- Intercept_Pharmaceuticals name "Intercept Pharmaceuticals, Inc.".
- Intercept_Pharmaceuticals type "Public".
- Intercept_Pharmaceuticals subject Category:Biotechnology_companies_of_the_United_States.
- Intercept_Pharmaceuticals subject Category:Companies_initially_financed_with_venture_capital.
- Intercept_Pharmaceuticals subject Category:Companies_listed_on_NASDAQ.
- Intercept_Pharmaceuticals subject Category:Pharmaceutical_companies_of_the_United_States.
- Intercept_Pharmaceuticals point "40.678631 -78.243038".
- Intercept_Pharmaceuticals type Agent.
- Intercept_Pharmaceuticals type Company.
- Intercept_Pharmaceuticals type Organisation.
- Intercept_Pharmaceuticals type Organization.
- Intercept_Pharmaceuticals type Agent.
- Intercept_Pharmaceuticals type SocialPerson.
- Intercept_Pharmaceuticals type Thing.
- Intercept_Pharmaceuticals type SpatialThing.
- Intercept_Pharmaceuticals comment "Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC), non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.".
- Intercept_Pharmaceuticals label "Intercept Pharmaceuticals".
- Intercept_Pharmaceuticals sameAs m.04f95dh.
- Intercept_Pharmaceuticals sameAs Q16997126.
- Intercept_Pharmaceuticals sameAs Q16997126.
- Intercept_Pharmaceuticals lat "40.678631".
- Intercept_Pharmaceuticals long "-78.243038".
- Intercept_Pharmaceuticals wasDerivedFrom Intercept_Pharmaceuticals?oldid=604185629.
- Intercept_Pharmaceuticals isPrimaryTopicOf Intercept_Pharmaceuticals.
- Intercept_Pharmaceuticals name "Intercept Pharmaceuticals, Inc.".